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ABSTRACT
Using an in vitro selection, we have obtained
oligonucleotide probes with high discriminatory
power against multiple, similar nucleic acid
sequences, which is often required in diagnostic
applications for simultaneous testing of such
sequences. We have tested this approach, referred
to as iterative hybridizations, by selecting probes
against six 22-nt-long sequence variants represent-
ing human papillomavirus, (HPV). We have obtained
probes that efficiently discriminate between HPV
types that differ by 3–7nt. The probes were found
effective to recognize HPV sequences of the type 6,
11, 16, 18 and a pair of type 31 and 33, either when
immobilized on a solid support or in a reverse
configuration, as well to discriminate HPV types
from the clinical samples. This methodology can be
extended to generate diagnostic kits that rely on
nucleic acid hybridization between closely related
sequences. In this approach, instead of adjusting
hybridization conditions to the intended set of
probe–target pairs, we ‘adjust’, through in vitro
selection, the probes to the conditions we have
chosen. Importantly, these conditions have to be
‘relaxed’, allowing the formation of a variety of not
fully complementary complexes from which those
that efficiently recognize and discriminate intended
from non-intended targets can be readily selected.
INTRODUCTION
Speciﬁc interactions between macromolecules or between
macromolecules and their low molecular weight ligands
are crucial in all biological processes. The study of speciﬁc
interactions requires the use of elaborate research tools
from various ﬁeld, such as molecular biology, medicine
and molecular diagnostics. The speciﬁcity, describing the
ability to discriminate between diﬀerent ligands, is often
equated with the aﬃnity between the interacting mole-
cules (1). A ligand of suﬃciently high aﬃnity is expected
to be highly speciﬁc for its target, and the high-aﬃnity/
high-speciﬁcity paradigm was considered applicable to
virtually all interacting systems (2). However, this para-
digm does not apply easily to nucleic acid hybridization,
which is fundamental to many techniques in molecular
genetics. Although it is true that the interaction between
nucleic acid strands becomes stronger with each addi-
tional base-pair and that a longer sequence precisely
identiﬁes one of many more possible nucleic acids than a
shorter sequence, in practice, the ability of an oligo- or a
polynucleotide to discriminate among closely related
sequences through hybridization actually decreases as a
function of sequence length. While there is a minimal
threshold length that has to be respected to render
the sequence unique within a complex genome, cross-
hybridization of similar but non-identical sequences
becomes more probable with longer sequences.
A number of computational tools have been developed
to assist oligonucleotide probe design using diﬀerent
criteria and diﬀerent algorithms for optimal probe
selection (3–8). A large-scale microarray study showed
that the majority of oligonucleotide probes did not behave
according to commonly assumed hybridization models
(9–11). Some authors suggested additional optimization
strategies that involve empirical criteria (12–14).
The possibilities of designing partly mismatched
probes (15–17) or probes aiming the secondary
structure of the target (8,18) are rarely considered in
probe-design programs. Recently, Pozhitkov et al. (19)
*To whom correspondence should be addressed. Tel: (514) 345-4931 ext. 3586/3282; Fax: (514) 345-4731; Email: ibrukner@hotmail.com
Correspondence may also be addressed to Damian Labuda. Tel: (514) 345-4931 ext. 3586/3282; Fax: (514) 345-4731;
Email: damian.labuda@umontreal.ca
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.even recommended against the application of probe-
design software tools that use thermodynamic parameters
to assess probe quality in discriminating related sequences;
their results implied that thermodynamic properties of
oligonucleotide hybridization are far from fully under-
stood. On the other hand, others have reported technical
improvements by the application of computational
methods in searching for active antisense oligonucleotides
(20), or in the design of oligonucleotide microarrays (21).
To avoid false priming, when performing PCR, the
annealing of primers is usually carried out at the highest
possible temperature that maximizes the stability gap
between complementary and mismatched duplexes.
However, if sequences that have to be distinguished are
similar, the diﬀerence in their binding energies is small,
thereby restricting the window of adjustable experimental
conditions that would allow discrimination between all
potentially reacting species. Finding such conditions may
become problematic in multiplex applications, when many
probes and/or many targets are considered simultaneously
(3,10,22,23). In such cases, there is a need to increase
the room for simultaneous adjustment of these conditions.
Or, as an alternative, one may try to adjust binding
characteristics of the probes, given the hybridization
conditions. How to create room for such adjustments
that require structural manipulation of the probes? Rather
than considering distinguishing between every variant of
sequence length L out of 4
L possible, we will only consider
targeting variants that really exist, or are of diagnostic
interest, and whose number is thus substantially smaller.
By lowering the complexity of the investigated pool of
target sequences, no more is there the need to maintain a
full-sequence match. Rather than increasing the aﬃnity to
increase speciﬁcity, which has to be subsequently enforced
by denaturing conditions, we propose to experimentally
relax binding conditions to allow the reduction in aﬃnity.
This can be done either by manipulating the composition
of the hybridization solution, by lowering the temperature
or both. As a result, the number of possible structural/
sequence variants of a probe(s) that can be used against
a particular target sequence is substantially increased.
In consequence, it allows choosing from this variety those
probes that would maximize the energy gap between
solicited, intended and unsolicited, non-intended com-
plexes with their targets. In other words, resigning from
fully or almost fully complementary complexes increases
the number of probe–target combinations from which
those that maximize the diﬀerences between all non-
intended complexes can be chosen; this is of special
interest in multiplex applications where a multiplicity of
targets have to be simultaneously tested. Moreover, all
such intended target–probe combinations can be chosen to
respect minimal threshold in energy diﬀerence between all
possible complexes to allow their eﬃcient discrimination
at a given experimental setting. This can be achieved by
evolutionary approach, through aﬃnity selection of
probes by iterative hybridization (15).
In order to test this approach, we used human
papillomavirus (HPV) as a model. The HPV family
consists of 4100 types, of which 39 types have been
detected in the anogenital mucosa. Several of mucosal
types have been associated with anogenital cancer, while
other types are not carcinogenic and produce genital
warts. A large variety of techniques are available for
detection and subtyping of HPV types, but neither of them
presents robust and complete solution to this problem
(24–29). Here, we demonstrate the feasibility of this
approach in designing probes against short DNA seg-
ments using target sequences representing six of the HPV
subtypes that diﬀer in only few nucleotide positions.
MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides were synthesized by Integrated DNA
Technologies (Coralville, IA). Target oligonucleotides
corresponding to the so-called short PCR fragment,
(SPF), described by Kleter et al. (25), consisted of
22-nt-long, HPV-type-speciﬁc segment, ﬂanked by 22-
and 23-nt-long PCR primers anchoring sequences as
illustrated in Figure 1. These 67-nt-long oligomers were
synthesized in two versions: non-modiﬁed and modiﬁed
at their 50 ends with biotin to allow for their immobiliza-
tion on streptavidin-coated solid supports. The corre-
sponding forward and reverse primers were used to
amplify the synthetic targets or the corresponding HPV
DNAs obtained from the clinical samples; these primers
were modiﬁed at their 50 ends by the addition of
6-carboxyﬂorescein (6-FAM) and the phosphate residue,
respectively.
Oligonucleotide probes were obtained by rounds of
hybridizations starting with a mixture containing
22-nt-long random sequence segment embedded within
constant sequence fragments to anchor PCR primers,
ROM22: GCCTGTTGTGAGCCTCCTGTCGAA-
(N)22-TTGAGCGTTTATTCTTGTCTCCCA, where
N-corresponds to A, G, C and T (equimolar during
synthesis). The following oligonucleotides were used to
block the ﬂanking primer-anchoring segments of ROM22:
50 blocker, TTCGACAGGAGGCTCACAACAGGC
and 30 blocker, 50P-TGGGAGACAAGAATAAACGCT
CAA. The oligonucleotide GCCTGTTGTGAGCCTCC
TGTCGAA, complementary to the 50 blocker, was used as
the forward primer and the 50-phosphorylated 30 blocker
as the reverse primer, serving in PCR to amplify (i) pools
of oligonucleotide mixtures [pooled probes (PPs)]
obtained after each cycle of hybridization or (ii) particular
probes [cloned probes (CPs)] from the plasmid clones
carrying individual oligonucleotide sequences. Finally,
target complements represented 22-nt-long complemen-
tary sequences of the HPV-type-speciﬁc SPF segments
listed in Figure 1, all modiﬁed at 50 end by the addition
of 6-FAM.
Clinical samples
DNA was extracted from six patients containing single-
type HPV. Initially, DNA was ampliﬁed with PGMY
primers (30) and typed by sequencing.
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Streptavidin-coated tubes (Roche Diagnostics GmbH,
Mannheim, Germany) and 96-well plates (Pierce Reacti-
Bind Streptavidin Coated High Binding Capacity Black
plates, Rockford, Il) were used for preparative and
analytical purposes, respectively. After washing three
times with 10mM Tris-HCl, pH 7.5, 10mM MgCl2 and
50mM NaCl (TMN buﬀer), the tubes (or plates) were
incubated with the predeﬁned amount, between 1 and
100pmol, of the 50 biotinylated target oligonucleotide for
at least 15min, rinsed three times with TMN buﬀer and
stored at 48C until used.
Amplification and conversion ofoligonucleotides into
single-stranded DNA
Following hybridization, the bound oligonucleotides were
dissociated from the target. These PPs were ampliﬁed by
PCR: the reaction was carried out in a total volume of
50ml containing 0.1–100fmol of the template in the
presence of 1mM each of the primers (Figure 1), 100mM
each of dNTPs, 10mM Tris-HCl, pH 8.3, 1.5mM MgCl2,
50mM KCl and 1U of Taq polymerase (Platinum,
InVitroGene). Typically, 27–30 PCR cycles were used,
consisting each of 30s at 948C, 30s at 538C and 30s at
728C. The quantity and quality of PCR products were
estimated by agarose gel-electrophoresis and/or by mea-
suring the 6-FAM ﬂuorescence of PCR amplicons, after
eliminating the non-incorporated primers, using the
Montage centrifuge ﬁlter device (Millipore, Billerica,
MA). These products were rendered single stranded by
incubation with 5 U of  exonuclease (NEB, Boston, MA)
that digests 50-phosphorylated strand, for 30min at 378C,
followed by 20min at 658C to inactivate the enzyme.
The same procedure was used to produce single-stranded
probes from PCR products from individual clones.
Hybridizations
The synthetic mixture of random oligonucleotides ROM22
(1nmol) was used in the initial hybridization to obtain the
ﬁrst generation of PPs. In all subsequent hybridizations,
the PPs from the preceding cycle were PCR ampliﬁed
and converted to the single-stranded form. Typically,
10–50pmol of single-stranded PP (0.05–0.25mM) obtained
in the previous cycle was mixed with two blocking
oligonucleotides to obtain 0.5mM each, in 200mlo f
TMN buﬀer and heated to 908C. This solution was
subsequently transferred to tubes containing pre-
bound biotinylated targets, then cooled down to
the ambient temperature, 22–248C, and left for at least
4h at this temperature. The tubes were then rinsed three
times with TMN buﬀer, and the probes that remained
bound to the targets were washed oﬀ by incubation
at 908C in 200ml of water for 2min. There was 1 pmol of
the added target per tube, except during the ﬁrst
hybridization when 100pmol were added (however, the
eﬀective amount of the available target for binding was
less, see below). Forward hybridizations were followed by
subtractive hybridizations carried as detailed above, but in
the presence of 0.5mM (total) of the non-desired oligo-
nucleotide targets (i.e. other than the immobilized target).
Probe - target Unintended target
(free in solution)
Diversity of probes Intended target
(bound to solid support)
Probe - unintended
target
Probes which are not bound
to intended target are discarded
Probes bound to intended
target are washed and enter
the next hybridization cycle
Forward hybridization
Mixture of
pooled probes
Probes cross-hybridizing with
unitended target are discarded
Specific probes washed
from intended target
Subtractive hybridization
Mixture of
pooled probes and
unintended targets
Figure 1. Schematic presentation of iterative hybridizations, composed of two steps: forward (left) and subtractive hybridizations (right). Intended
and non-intended targets, probes and complexes between them are drowned in the legend (down). Note that intended targets are attached to the solid
support, while non-intended targets are free in solution.
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Target oligonucleotides, representing SPF of diﬀerent
HPV types, were immobilized in separate wells of 96-well
plates (under saturation with target, the resulting eﬀective
amount of the target per well was  17pmol, when
measured as its amount available for binding with its
6-FAM-labeled complement). PPs or CPs (0.1–0.5mM,
converted to single strands) were incubated with immobi-
lized targets, in the presence of 1mM each of the block
oligonucleotides, in 100ml of TMN buﬀer for 4h at 228C.
The wells were rinsed three times with 100ml of TMN
buﬀer and the bound 6-FAM ﬂuorescence (in relative
ﬂuorescence units, RFUs) was measured directly in
Spectra MAX Gemini XS (228C, ex¼485nm and
em¼538nm). The binding experiments with the 6-FAM
labeled, 22-nt-long target complements were carried out
using the same protocol, except that blockers were not
added.
Competitive binding
The binding was measured as above, with 6-FAM-labeled
oligonucleotides (PP, CP or complements) kept at a
constant concentration of 10–50pmol/well (0.1–0.5mM),
in the presence of increasing concentrations, from 0 to
10mM, of target competitor. The latter was the non-
biotinylated SPF oligonucleotide, either identical with the
immobilized target (homologous competitive binding), or
representing the SPF sequence of another HPV type
(heterologous competitive binding). The EC50 values were
estimated from the data according to the equation
calculated from using the GraphPad Prism Software
(Version 4).
Cloning andsequencing ofindividual probes
Cloning the probes from the PPs was done using TOPO
TA Cloning kit (Invitrogen, CA). Typically, 20 positive
clones were selected using X-Gal/IPTG-based-
colorimetric reaction, following the manufacturer’s
protocol. The M13 forward and reverse primers were
used to conﬁrm the presence of the insert and to ‘extract’ it
for subsequent direct sequence determination using LiCor
apparatus (Lincoln, NE). In turn, the resulting CPs were
produced by PCR using ROM22 primers and tested for
binding.
Reverse format hybridization
The sequences of the CPs with the best signal-to-noise
ratio were chemically synthesized Integrated DNA
Technologies (IDT) with a biotin moiety at their 50 end.
Individual 50 biotinylated probes were bound (100pmol)
to streptavidin-coated plates. The HPV SPF was gener-
ated by PCR either from the typed DNA obtained from
clinical samples or from the synthetic target oligonucleo-
tides (Figure 1), using 0.1fmol of the template and the
corresponding 6-FAM-labeled and 50-phosphorylated
forward and reverse primers (0.15mM of each), following
Kleter’s procedure (25). The reaction was carried out in
50ml in the presence of 100mM of each of dNTPs, 10mM
Tris-HCl (pH 8.3), 1.5mM MgCl2, 50mM KCl and 1 U of
Taq polymerase (Platinum, InVitroGene), for 40 cycles,
consisting of 30s incubation at 948C, 30s at 528C and 30s
at 728C. The PCR products (10–30pmol) were converted
to single-stranded DNA and mixed with 200pmol of each
of the blockers (2-fold excess over the added immobilized
probe). Prior to transferring into the micro-titer well, this
mixture was heated to 908C and the hybridization was
performed overnight or for at least 4h at the ambient
temperature. The wells were washed three times with
TMN buﬀer and the ﬂuorescence was directly measured in
Spectra MAX Gemini XS and at 228C as described.
RESULTS
We carried out a series of iterative hybridizations to select
probes recognizing six sequence variants of the ‘short PCR
fragment’, SPF (25). This technique consists of two
hybridization steps, as illustrated in Figure 1: forward
(þ) hybridization shown on the left and subtractive ( )
hybridization on the right. The intended target for which
we are selecting the puobes is bound to the solid support
(such as streptavidin-coated tubes) in both the forward
and the subtractive hybridization. The non-intended
targets we want to discriminate against are present only
in the subtractive steps, as a competing species, free in
solution. The initial pool of random oligonucleotides is
present in the hybridization solution at the ﬁrst step of the
selection and is subsequently replaced by the ‘reduced’
oligonucleotide pools resulting from each preceding step
along the selection process. Here, SPF targets consisted of
22-nt-long ampliﬁed portion ﬂanked by 22- and 23-nt-long
primer sequences (Figure 2A). They represented diﬀerent
HPV types 6, 11, 16, 18, 31 and 33, diﬀering by 3–7nt
within the ampliﬁed portion (Figure 2B) with types 31 and
33 diﬀering only by 1nt position that will be considered
together eventually. Synthetic, biotinylated target oligo-
nucleotides were immobilized in the streptavidin-coated
tubes and were hybridized to synthetic random oligonu-
cleotide mixture, ROM22, consisting of 22-nt random
sequence ﬂanked by two 24-nt-long primer sequences.
Following the ﬁrst hybridization, the unbound ROM22
oligonucleotides were washed away and the bound ones
were dissociated from their targets, re-ampliﬁed by PCR
and hybridized again. Each hybridization cycle enriched
the resulting mixture of PPs in sequences that were
eﬃciently binding their targets. Yet, as can be seen in
Figure 3A, some of these PPs obtained after ﬁve forward
hybridizations (5þ), bind non-intended targets almost as
well as their corresponding intended targets. As shown in
Figure 3B, the speciﬁcity of the resulting PP was
dramatically improved after they were submitted to
three additional cycles of subtractive hybridization per-
formed simultaneously, i.e. in the presence of mixture of
non-intended targets (5þ 3 ). The intensity of the speciﬁc
signal (diagonal) remained the same, whereas the
non-speciﬁc hybridization was substantially decreased, to
the background level at several instances. Thus, the
performance of PP submitted to the process of iterative
hybridization that includes subtractive cycles largely
surpass that of the PP obtained when this process
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shown in Figure 3, PPs at the end of 5þ 3  cycles also
perform much better than the 22-nt-long complements
of the analyzed targets. These complements, when used
as probes, readily cross-hybridize with the mismatched
non-intended targets (Figure 3C).
An important characteristic of a performing probe is to
similarly discriminate, at given experimental conditions,
all possible non-intended targets. In other words, a certain
threshold of aﬃnity diﬀerence has to be respected between
the intended and all possible undesired complexes. The
capacity of discrimination between diﬀerent targets can be
studied by competitive hybridization in which the extent
of the probe–target complex is measured at varying
concentrations of the competitor. If the target is immo-
bilized and the probe is labeled, one may titrate the
complex by increasing the concentration of the free
targets. The eﬀective concentration required to dissociate
50% of the original complex, EC50, provide a measure of
the competitor binding. The diﬀerence between EC50 for
the intended oligonucleotide target and the EC50 esti-
mates for the non-intended oligonucleotide targets pro-
vides the measure of the discrimination capacity of the
probe. It reﬂects the diﬀerence in the binding constants,
which are expected to have similar temperature depen-
dence here. In other words, it should not be aﬀected by the
fact that the measurements are carried out below the
melting temperatures of the corresponding complexes.
Figure 4 illustrates the titration experiment carried out
with the immobilized HPV16 variant and diﬀerent probes.
In Figure 4A, the complement 16 was used as a probe. It
discriminates very well against target HPV18 (T18). Yet,
at the same time, it shows logEC50 diﬀerence between the
intended T16 and T6 of only 0.4, indicating very poor
discrimination. This can also be directly appreciated by
looking at the corresponding titration curves that almost
overlap in Figure 4A. In contrast, PP16 shown in
Figure 4B discriminates similarly between intended T16
and other targets with logEC50 diﬀerence of 1.0 or more.
Here, T18 and T6 compete with the intended T16–PP16
complex very similarly, in spite of the fact that the ﬁrst
diﬀer from T16 by 7 and the second by only 3-nt positions
(Figure 2B). Clearly, PP16 reveals desired characteristics
of a probe that similarly discriminates multiple targets.
It was chosen to be shown here since its intended target
diﬀers by only 3nt from the closest HPV6 sequence.
On the other hand, in these experiments we were unable to
obtain PP31 and PP33 that would eﬃciently discriminate
between the corresponding targets diﬀering by only 1nt.
Instead we obtained PP31/33 recognizing both targets
simultaneously.
Since each of the speciﬁc PP, following 5þ 3  cycles of
iterative hybridization described above, consists of a
mixture of diﬀerent sequences, it can be expected that
they comprise a smaller fraction of the sequences with
even better binding characteristics. The corresponding
unique sequence probes, CP for cloned probe, were
obtained by cloning PPs into the plasmid vector.
Individual CPs were extracted from the plasmids by
PCR and tested for binding to the intended and non-
intended targets. It usually took less than ﬁve clones, to
obtain one with the desired, arbitrarily deﬁned ratio of at
least ﬁve to one of the speciﬁc to non-speciﬁc binding. The
one with the best discrimination performance was
sequenced and retained for further analysis. The sequences
of the selected CPs (without ﬂanking primer sequences)
A                               6602                 6623
HPV  6-FAM-gcacacagggccacaataatgg>
T16     Bt-gcacacagggccacaataatggCATTTGTTGGGGTAACCAACTAtttgttactgttgttgatactac
T6         ......................T..............T.....G.......................
T11        ......................T.....C.....A.....CT.G.......................
T18        ......................TG....C...CA...T...T.........................
T31        ......................T...........C..T..GT.........................
T33        ......................T...........C..T..GG.........................
<aaacaatgacaacaactatgatg-P 
HPV  6  11  16  18  31  33
  6  0   5   3   6   4   4
 11      0   6   7   5   6
 16          0   7   5   5 
 18              0   6   7
 31                  0   1
 33                      0
B
Figure 2. Target short PCR fragment, SPF, of distinct HPV subtypes. Twenty-two-nucleotide-long ampliﬁed sequence is ﬂanked by sequences used
to anchor the PCR primers as indicated (A) and the matrix of pairwise nucleotide diﬀerences between the SPF sequences considered (B). Bt and
6-FAM denote 50 terminal modiﬁcations with biotin and 6-carboxyﬂuorescein, respectively. Dots indicate the identity with the upper sequence.
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intended targets, highlighting sites possibly engaged in the
complementary interactions.
CPs performed better than PPs as far as the detection of
their intended targets and discrimination against the non-
intended ones is concerned (Figure 6A). In a competitive
titration shown in Figure 4C, CP16 performed on average
also better than its maternal PP16 (Figure 4B) as judged
by logEC50 values in Figure 4B and C. Yet, presumably
because of the fact that CP16 represents an individual
clone, the variance in logEC50 values in Figure 4C
appears greater than in Figure 4B, although some of this
variance can also be accounted for by non-uniformity of
the streptavidin coating between wells within the plates
used in these measurements (Materials and methods
section). Finally, in binding experiments including all
targets (Figure 6A), CPs gave the same hybridization
signal as their corresponding PPs (Figure 3B), but less
background hybridization. Furthermore, the advantage of
CPs over their maternal PPs is that they provide a
possibility to test their eventual use as tools in diagnostic
tests that require hybridization in the reverse conﬁgura-
tion, with probes immobilized to the solid support.
Indeed, all the experiments reported so far were in the
‘forward blot format’, with the immobilized targets. In the
‘reverse blot format’, the probes, with biotin moiety at
their 50 end, are themselves immobilized and therefore can
provide a simultaneous test for the presence of diﬀerent
targets, such as distinct HPV variants in a clinical sample.
This corresponds to the diagnostic situation where the
target sequence ampliﬁed from a clinical sample is being
tested in a panel of immobilized probes intended to
identify the presence of a speciﬁc HPV subtype. As
shown in Figure 6B, CPs are performed in the reverse blot
format very well, although we noted a lesser binding of
targets resulting in a slightly less favorable signal to the
background hybridization ratio than in the direct format.
This, however, did not compromise the test. Similar
results were obtained when clinical samples of known
HPV type were used as a source of the HPV SPF segment
tested.
Figure 3. Binding of probes to their intended and non-intended targets.
(A) Binding of the pool of probes, PPs, obtained after ﬁve rounds of
forward hybridization (5þ); (B) binding of PPs after they were
submitted to three additional rounds of subtractive hybridizations
(5þ 3 ); and (C) binding of the full 22-nt-long complements of the
targets. All probes were labeled with 6-FAM at their 50 terminus to
allow quantiﬁcation of the extent of hybridization, expressed in
arbitrary units and corresponding to the bound measured ﬂuorescence
signal (RFU—relative ﬂuorescence units).
Figure 4. Competitive titration of the immobilized HPV-16 target
(T16). T16 was hybridized with its 6-FAM-labeled complement in (A),
PP16 (5þ 3 )i n( B) and cloned probe CP16 (see Figure 5 for the
corresponding sequence) in (C). The bound ﬂuorescence was chased by
increasing the concentrations of the non-biotinylated T16 target or each
of the non-biotinylated non-intended target oligonucleotides. The
eﬀective concentration EC50 of the competitive target oligonucleotides
required to reduce the binding by 50% was calculated, expressed as
logEC50. logEC50 is the diﬀerence between the logEC50 values
obtained for T16 and a competitive non-intended target as indicated.
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The selection in vitro (or in vitro ‘evolution’ of nucleic acid
ligands) has rarely been used against nucleic acid targets
(31–34) and has never been used to select probes for
genotyping. One reason for this was the prevailing dogma
that binding speciﬁcity between nucleic acids is best
achieved through complementary interactions and that
these can be easily programmed according to Watson–
Crick rules (but see 31). The second reason was the
experimental diﬃculty related to the interference of these
complementary interactions in the process of selection of
nucleic acid ligands against nucleic acid targets. The
solution to the latter problem was proposed by Brukner
et al. (15). Here, we modiﬁed the protocol described
by (15), referred to as iterative hybridization to distinguish
from the in vitro selection protocols involving non-nucleic
acid targets. The novel application of this technology
was to obtain probes for genotyping sequence variants
diﬀering by only few nucleotide positions. Because of the
diagnostic importance of HPV typing and the variety of its
sequence variants, we used HPV as a model system to test
this approach. However, we used only six most common
oncogenic and non-oncogenic HPV targets. Therefore, the
probes we have obtained are not expected to discriminate
against other HPV variant SPF sequences.
Iterative hybridization is an empirical approach using
in vitro selection that does not rely on the rational design
of hybridization probes limited by our imperfect knowl-
edge of complex physico-chemistry of the nucleic acid
interactions. Selection in vitro allows exploring a whole
space of potential probes within an initial pool of random
sequences and, importantly also, all possible combinations
of binding conﬁgurations of these probes with their
targets, given conditions of selection. As we have shown
above, forward hybridization enriched PPs in the oligo-
nucleotide ligands with binding capacities. In turn, the
discriminatory binding was achieved by subtractive
hybridization that purged the selected ligands also
     T6   GCACAGGGCCACAATAATGGTATTTGTTGGGGTAATCAACTGTTTGTTACTGTTGTTGATACTAC                                         .......... .....  ...  .                                    CP6                                 GGTAATCAACAGTTTGA-ACTACT
    T11   GCACAGGGCCACAATAATGGTATTTGCTGGGGAAACCACTTGTTTGTTACTGTTGTTGATACTAC                                    ...........
   CP11                            GCTGGGGAAAC
    T16   GCACAGGGCCACAATAATGGCATTTGTTGGGGTAACCAACTATTTGTTACTGTTGTTGATACTAC                                                .......... ....
   CP16                                        AACTATTTGT-ACTG
    T18   GCACAGGGCCACAATAATGGTGTTTGCTGGCATAATCAATTATTTGTTACTGTTGTTGATACTAC                              ..... .......
   CP18                      GTGTTCGCTGGCA
    T31   GCACAGGGCCACAATAATGGTATTTGTTGGGGCAATCAGTTATTTGTTACTGTTGTTGATACTAC
    T33   GCACAGGGCCACAATAATGGTATTTGTTGGGGCAATCAGGTATTTGTTACTGTTGTTGATACTAC                                        .......... ..
CP31/33                       AGAACCAAAGGGCAATCAGTTA
10 20 20 40 50 60
|||||||||||||
Figure 5. Cloned probes, CPs, in the context of their intended target sequences. Diﬀerences in the SPF targets are highlighted, whereas dots indicate
matches between targets and the corresponding CPs. Note that the CP sequences are ﬂanked by priming sequences that are not shown. Alignment of
given sequences was performed using BLAST engine for local alignment (36).
Figure 6. Binding of the individual cloned probes: in (A) to the immo-
bilized intended and non-intended HPV targets, and in (B) the same
binding, but in reverse format instead, i.e. of the free PCR-ampliﬁed,
tested HPV targets to the intended and non-intended immobilized
cloned probes from Figure 4.
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we obtained speciﬁc PPs with desired characteristics
‘programmed’ by selection. In this process, instead of
adjusting hybridization conditions to the desired set of
probe–target pairs, we ‘adjusted’ the probes to the
conditions we have chosen. Importantly, however, these
conditions have to allow a ‘relaxed’ binding, i.e. such that
would readily occur even in the absence of the full
saturation of all potential base pairs of the target with its
complementary probe. Indeed, the key characteristics of
the selected probes (Figure 5) are that they do not
represent exact complements of the target sequence. It
appears that when several sequences are to be simulta-
neously tested, diﬀerent number and position of mis-
matches may minimize cross-reactivity of multiple similar
targets without compromising the stability of each of the
intended probe–target pairs. Interestingly, although we
have started with the initial random sequence, which
happened to be of the same length as 22-nt-long SPF
targets, most of the selected probes were substantially
shorter (Figure 5). Selecting shorter sequences turned
to be ‘cheaper strategy’ than to accommodate non-
complementary sequence gaps. CP31/33 is an exception
here. It retained the initial 22-nt length forming a 9-nt 30
end mismatched tail that apparently did not interfere by
binding to non-intended targets. At the same time, some
of the probes (CP6 and CP16) used an extended target
sequence evolving matches within its constant ﬂanking
segment, i.e. beyond 22-nt-long SPF segment. In other
words, we observe shortening of the probes and
‘extending’ of the target sequence, which may be part of
the strategy of in vitro evolution. The latter perhaps
because of the limited size of the SPF target itself. As for
mismatches, we may speculate that increasing the tem-
perature of the experiment could decrease their number in
the selected complex.
If we have k targets to discriminate in a single test, we
have to select the same number of probes. In each
experiment, we use all the remaining k 1 targets as non-
intended ones for subtractive hybridization. Since all
iterative hybridization steps are carried out under uniform
conditions, the resulting PPs are immediately ready for use
in a multiplex assay where all probes should recognize
their targets and discriminate against the remaining ones.
Yet, they represent mixtures of probes and cloning
individual sequences render them easier to propagate.
Moreover, since mixture of probes also represents
‘mixture’ of binding characteristics, we expected to be
able to choose from this distribution the individual probes
with even better binding characteristics. This appears to be
the case, at least as judged by the competitive binding
experiments and the corresponding logEC50s (Figure 4).
In conclusion, we have presented here a protocol that
yields oligonucleotide sequences capable of discriminating
between multiple nucleic acid targets that diﬀer by as little
as 3nt. The HPV model used here can be extended to the
whole set of 39 epidemiologically important HPV types,
targeting SPF or other relevant HPV segments, to create
simple diagnostic devices in clinical research and in
predictive testing (Brukner et al. submitted for publica-
tion). Eventually, the analysis of an extended dataset
obtained from such experiments can also be used to
gain new knowledge about nucleic acid–nucleic acid
interactions and improve rules of the rational probe
design (e.g. 31,35).
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